180 Life Sciences Corp. Files 8-K Report

Ticker: FRMM · Form: 8-K · Filed: Jul 1, 2025 · CIK: 1690080

180 Life Sciences CORP. 8-K Filing Summary
FieldDetail
Company180 Life Sciences CORP. (FRMM)
Form Type8-K
Filed DateJul 1, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: filing, corporate-update

TL;DR

180 Life Sciences filed an 8-K on 7/1/25, check for updates.

AI Summary

On July 1, 2025, 180 Life Sciences Corp. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material events detailed in the provided text. The company, formerly KBL Merger Corp. IV, is incorporated in Delaware and headquartered in Palo Alto, California.

Why It Matters

This 8-K filing indicates that 180 Life Sciences Corp. is providing updates or submitting required documentation to the SEC, which could contain material information for investors.

Risk Assessment

Risk Level: low — The provided text is a standard 8-K filing notification and does not contain specific financial or operational details that would indicate high risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The filing is a Current Report on Form 8-K, indicating it's for 'Other Events' and 'Financial Statements and Exhibits', filed on July 1, 2025.

When was the earliest event reported in this filing?

The earliest event reported is dated July 1, 2025.

What was the former name of 180 Life Sciences Corp.?

The company was formerly known as KBL Merger Corp. IV.

In which state is 180 Life Sciences Corp. incorporated?

180 Life Sciences Corp. is incorporated in Delaware.

What is the business address of 180 Life Sciences Corp.?

The business address is 3000 El Camino Real, Bldg. 4, Suite 200, Palo Alto, CA 94306.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 1, 2025 regarding 180 Life Sciences Corp. (FRMM).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing